Vitamin D status and its association with gradual decline in cognitive function.

BACKGROUND/AIM To compare plasma vitamin D concentrations among patients with normal cognitive function (control group), mild cognitive impairment (MCI), and Alzheimer disease (AD). MATERIALS AND METHODS In total, 158 patients with AD, 228 patients with MCI, and 603 control subjects were included. Plasma levels of 25-hydroxyvitamin D were measured after comprehensive geriatric assessment and compared among groups. SPSS 15.0 was used for statistical analysis. RESULTS Mean levels of 25-hydroxyvitamin D were significantly different among the 3 groups of AD patients, MCI patients, and controls (P < 0.001). Post hoc analysis revealed that the levels were significantly lower in the MCI group than the control group (P = 0.002) and significantly lower in the AD group than the control group (P = 0.003). Multivariate analysis showed that age (OR: 1.070, 95% CI: 1.025-1.116, P = 0.002), instrumental activities of daily living score (OR: 0.920, 95% CI: 0.850-0.995, P = 0.037), 25-hydroxyvitamin D level (OR: 0.959, 95% CI: 0.932-0.987, P = 0.004), and diabetes mellitus (OR: 2.476, 95% CI: 1.153-5.319, P = 0.020) were factors independently associated with AD. CONCLUSION This study demonstrated that there is a correction between plasma 25-hydroxyvitamin D levels and cognitive functions.

[1]  C. Annweiler,et al.  Vitamin D in Older Adults: The Need to Specify Standard Values with Respect to Cognition , 2014, Front. Aging Neurosci..

[2]  A. Sinclair,et al.  Progression of Alzheimer disease in Europe: data from the European ICTUS study. , 2012, Current Alzheimer research.

[3]  Hans Förstl,et al.  Vitamin D Deficiency, Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis , 2012, Dementia and Geriatric Cognitive Disorders.

[4]  C. Annweiler,et al.  Vitamin D insufficiency and mild cognitive impairment: cross‐sectional association , 2012, European journal of neurology.

[5]  D. Steffens,et al.  Instrumental Activities of Daily Living Measure , 2012 .

[6]  C. Annweiler,et al.  Vitamin D-Mentia: Randomized Clinical Trials Should Be the Next Step , 2011, Neuroepidemiology.

[7]  C. Annweiler,et al.  [Vitamin D in the elderly: 5 points to remember]. , 2011, Geriatrie et psychologie neuropsychiatrie du vieillissement.

[8]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.

[9]  D. Le Gall,et al.  SEVERE VITAMIN D DEFICIENCY IS ASSOCIATED WITH ADVANCED‐STAGE DEMENTIA IN GERIATRIC INPATIENTS , 2011, Journal of the American Geriatrics Society.

[10]  E. Capetillo-Zarate,et al.  Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease , 2010, Acta Neuropathologica.

[11]  Anton P. Porsteinsson,et al.  Meta-Analysis of Alzheimer's Disease Risk with Obesity, Diabetes, and Related Disorders , 2010, Biological Psychiatry.

[12]  J. Cauley,et al.  25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men , 2010, Neurology.

[13]  C. Annweiler,et al.  Vitamin D and cognitive performance in adults: a systematic review , 2009, European journal of neurology.

[14]  A. Silman,et al.  Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men , 2009, Journal of Neurology, Neurosurgery, and Psychiatry.

[15]  J. Morris,et al.  Vitamin D deficiency is associated with worse cognitive performance and lower bone density in older African Americans. , 2009, Journal of the National Medical Association.

[16]  B. Astor,et al.  25-hydroxyvitamin D levels and the risk of mortality in the general population. , 2008, Archives of internal medicine.

[17]  E. Rimm,et al.  25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. , 2008, Archives of internal medicine.

[18]  K. Aytemir,et al.  Assessment of Endothelial Function in Alzheimer's Disease: Is Alzheimer's Disease a Vascular Disease? , 2007, Journal of the American Geriatrics Society.

[19]  Murat Emre,et al.  Association between vitamin D receptor gene polymorphism and Alzheimer's disease. , 2007, The Tohoku journal of experimental medicine.

[20]  A. Kalueff,et al.  Neurosteroid hormone vitamin D and its utility in clinical nutrition , 2007, Current opinion in clinical nutrition and metabolic care.

[21]  W. Willett,et al.  Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. , 2006, The American journal of clinical nutrition.

[22]  S. Nagpal,et al.  Noncalcemic actions of vitamin D receptor ligands. , 2005, Endocrine reviews.

[23]  R. Tanzi,et al.  Twenty Years of the Alzheimer’s Disease Amyloid Hypothesis: A Genetic Perspective , 2005, Cell.

[24]  C. Jack,et al.  Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment , 2004, Journal of internal medicine.

[25]  R. Petersen.  Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.

[26]  Heping Zhang,et al.  Basal Ganglia volumes in patients with Gilles de la Tourette syndrome. , 2003, Archives of general psychiatry.

[27]  François Berger,et al.  New clues about vitamin D functions in the nervous system , 2002, Trends in Endocrinology & Metabolism.

[28]  P. Thomas,et al.  ALZHEIMER'S DISEASE AND VASCULAR FACTORS: FACTS AND THEORIES , 2002, International journal of clinical practice.

[29]  J. McGrath,et al.  Vitamin D: the neglected neurosteroid? , 2001, Trends in Neurosciences.

[30]  L. Rubenstein,et al.  The Mini Nutritional Assessment-Short Form for preoperative nutritional evaluation of elderly patients , 2001, Aging.

[31]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[32]  A. Monsch,et al.  Early Diagnosis of Dementia via a Two-Step Screening and Diagnostic Procedure , 1997, International Psychogeriatrics.

[33]  J Rabe-Jabłońska,et al.  [Anxiety disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association: diagnostic and statistical manual of mental disorders (DMS-IV -- options book]. , 1994, Psychiatria polska.

[34]  V. Luine,et al.  1,25-Dihydroxyvitamin D3 treatment results in increased choline acetyltransferase activity in specific brain nuclei. , 1986, Endocrinology.

[35]  D Kromhout,et al.  The inverse relation between fish consumption and 20-year mortality from coronary heart disease. , 1985, The New England journal of medicine.

[36]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[37]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[38]  T. Oppé,et al.  Vitamin D deficiency. , 1979, British medical journal.

[39]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[40]  M. Lawton,et al.  Assessment of older people: self-maintaining and instrumental activities of daily living. , 1969, The Gerontologist.

[41]  C. Annweiler,et al.  Low serum vitamin D concentrations in Alzheimer's disease: a systematic review and meta-analysis. , 2013, Journal of Alzheimer's disease : JAD.

[42]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.